📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mutations in Ribosomal Protein RplA or Treatment with Ribosomal Acting Antibiotics Activates Production of Aminoglycoside Efflux Pump SmeYZ in Stenotrophomonas maltophilia. (2020)

First Author: Calvopiña K

Attributed to: One Health Drivers of Antibacterial Resistance in Thailand funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.01524-19

PubMed Identifier: 31712205

Publication URI: http://europepmc.org/abstract/MED/31712205

Type: Journal Article/Review

Volume: 64

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 2

ISSN: 0066-4804